FTSE 100 subdued as US stocks see modest pullback from record highs

The FTSE 100 struggled for direction on Tuesday as US stocks dipped a little from the previous day's record highs.

By the close the index...

Tue, 09/02/2021 - 16:36


Director Deals - (PHNX)

Rakesh Thakrar, Executive Director, bought 21 shares in the company on the 5th February 2021 at a price of £7.05. The Director now holds 14,925...

Tue, 09/02/2021 - 15:03


Director Deals - (PHNX)

Rakesh Thakrar, Executive Director, has transferred in 7 shares in the company on the 5th February 2021 at a price of £0.00. The Director now...

Tue, 09/02/2021 - 15:03


Director Deals - (PHNX)

Andrew Briggs, Chief Executive Officer, bought 21 shares in the company on the 5th February 2021 at a price of £7.05. The Director now holds...

Tue, 09/02/2021 - 15:03


Director Deals - (PHNX)

Andrew Briggs, Chief Executive Officer, has transferred in 7 shares in the company on the 5th February 2021 at a price of £0.00. The Director...

Tue, 09/02/2021 - 15:03


Sensyne Health strikes Covid-19 testing deal with Excalibur

Sensyne Health has licenced its MagnifEye technology to Excalibur Healthcare Services for use with lateral flow diagnostic tests, including Covid-19.

The MagnifEye system is a...

Tue, 09/02/2021 - 13:58


Altus granted four gold exploration licences in eastern Egypt

Mining company Altus Strategies has been granted four gold exploration licences for its subsidiary Akh Goldin in eastern Egypt by the Egyptian Mineral Resource Authority....

Tue, 09/02/2021 - 13:17


FTSE 100 going nowhere fast thanks to strong pound

Despite strong gains of oil stocks on a further advance in Brent crude the FTSE 100 was hamstrung by sterling strength on Tuesday.

By midday...

Tue, 09/02/2021 - 12:06


Ocado says pandemic has permanently changed grocery shopping, and TUI still hopes for summer recovery

“The FTSE 100 was tripped up by a familiar foe on Tuesday as a rise in sterling to near three-month highs against the dollar saw...

Tue, 09/02/2021 - 10:15


ImmuPharma phase 3 trial of lupus drug remains on schedule to begin in H2

Drug discovery and development company ImmuPharma said the phase 3 trial of its lupus drug candidate remains on schedule to begin in the second half...

Tue, 09/02/2021 - 10:07


Pages